Picture of Genovis AB logo

GENO Genovis AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for Genovis AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line24.58.2854.245.721.3
Non-Cash Items5.775.889.52-19.911.3
Other Non-Cash Items
Changes in Working Capital15.6-15.14.0111.3-0.523
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities45.9-0.92867.837.132
Capital Expenditures-4.49-3.83-12.8-4.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items19.2-53.5
Acquisition of Business
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-4.49-3.83-12.814.4-53.5
Financing Cash Flow Items15.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-4.23-3.73-4.51-5.3615.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash37.2-8.4850.446.2-6.25